Legend Capital, established in 2001 and based in Beijing, China, is a prominent venture capital firm and a subsidiary of Legend Holdings Ltd. The firm focuses on investing in high-growth ventures primarily within China or related markets, managing approximately US$700 million across multiple funds. Legend Capital emphasizes early-stage investments in the information technology sector, particularly in network applications and services, as well as in infrastructure and professional services. Additionally, it targets mid-market growth companies in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. With a portfolio of over 60 companies, Legend Capital actively supports its investments by providing extensive business resources and tailored services, aimed at enhancing business development and brand building in the Chinese market.
10/F, Tower A, Raycom Info.Tech Center, No.2 Ke Xue Yuan Nanlu, Zhong Guan Cun, Haidian District, Beijing 100190, China
Daqing Cai
Managing Director
Hao Chen
Managing Director and Head of Investment
Raymond CHEN
Co-Chief Investment Officer
Rui Chen
Managing Director
Frank Hong
Managing Director
Henry Ji
Executive Director
Yi Kang
Director
Richard Li
President
Jiaqing Li
Managing Director
Xiangyu Ouyang
Managing Director
Joon Sung Park
Executive Director
FAN Qihui
Executive Director
Jenking Shao
Managing Director and Partner
Zhenxing Shao
Partner / Managing Director
Jeff Wang
Managing Director
Junfeng Wang
Managing Director
Nengguang Wang
Managing Director and CFO
Piau-Voon Wang
COO
Tony WANG
VP
Ge Xinyu
Managing Director
Quan Zhou
Managing Director, Partner
Hank Zhou
Executive Director
Hongbin Zhou
Managing Director
William Wen
Executive Director
Past deals in Series C
Angitia Biopharmaceuticals
Series C in 2024
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.
Leapstack
Series C in 2023
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
Jinqirui Biology
Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.
Bio-Engine
Series C in 2023
Bio-Engine is a developer of high-density serum-free suspension culture technology for animal cells. Its main products include HEK293 cell serum-free medium, PK15 cell serum-free medium, etc., which can be applied to antibodies, recombinant proteins, human and livestock. Virus vaccine, cell therapy and other fields.
TriApex
Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.
Tripod Preclinical Research
Funding Round in 2023
Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.
ZStack
Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.
SJ Semi
Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.
ProBio
Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.
ClinBrain
Series C in 2022
ClinBrain develops a hospital information integration platform aimed at improving healthcare services through the digitization and standardization of patient data alongside medical and clinical data. This platform is designed to enhance the efficiency of medical research by providing hospitals with comprehensive healthcare big data services. By facilitating the integration of diverse data sources, ClinBrain supports healthcare professionals in making informed decisions and advancing medical research initiatives.
VectorBuilder
Series C in 2022
VectorBuilder is an online platform specializing in vector cloning and gene delivery solutions, catering to a range of needs from basic scientific research to clinical applications. The platform enables researchers to design and order custom gene delivery vectors efficiently, streamlining the process of vector construction and production. VectorBuilder offers a comprehensive suite of services, including vector customization, virus packaging, and advanced capabilities in adeno-associated virus capsid engineering. Additionally, the company provides Contract Research Organization (CRO) services and operates state-of-the-art facilities compliant with Good Manufacturing Practices (GMP), ensuring high-quality gene delivery tools for life sciences research and drug development.
Leadrive
Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.
Tianfu
Series C in 2022
Tianfu is a software enterprise. The company serves domestic and foreign manufacturing companies, domestic military units, universities, and scientific research institutes. The company's services include smart design solutions, industrial AI operation and maintenance, and software custom development. It also provides customized development services for corporate customers, including CAE pre-processing development.
TBSTest
Venture Round in 2022
TBSTest Technology is a developer and manufacturer of automatic test equipment for integrated circuits, specializing in ultra-large-scale integrated circuit testing. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an and Shanghai, as well as Suwon, South Korea, the company provides a comprehensive range of products, including test boards, software solutions, and memory systems. TBSTest Technology also offers pre-sales and after-sales support for its equipment, accessories, and software systems, along with application development projects. The company serves a diverse clientele, including clients engaged in integrated circuit design and production, as well as scientific research institutions and educational establishments.
Hoteam Software
Series C in 2022
Hoteam Software is a provider of intelligent manufacturing solutions aimed at transforming enterprise operations. The company emphasizes independent innovation and the development of controllable industrial software to support the advancement of China's industrial sector. Hoteam Software specializes in 3D software and offers a comprehensive range of services, including computer-aided design (CAD), computer-aided manufacturing (CAM), computer-aided process planning (CAPP), product data management (PDM), product lifecycle management (PLM), manufacturing execution systems (MES), warehouse management systems (WMS), and supplier relationship management (SRM). By leveraging its technology platforms, Hoteam Software enables industrial enterprises to enhance work efficiency and reduce operational costs through three-dimensional design, intelligent management, and visualization capabilities.
Zshield
Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.
Leapstack
Series C in 2021
Leapstack is an insurance technology company based in Shanghai, with additional offices in Beijing and Nanjing. Founded in February 2016, it focuses on developing big data artificial intelligence solutions tailored for commercial insurance companies and social security management agencies. The company's platform enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, anti-fraud measures, and compliance identification. By addressing inefficiencies in the industry, Leapstack aims to improve operational effectiveness and provide comprehensive data analysis and management tools for its clients.
ESWIN Computing
Series C in 2021
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.
H.Extract
Series C in 2021
H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.
QANDA(Mathpresso)
Series C in 2021
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.
Horizon Robotics
Series C in 2021
Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. operates an authoritative online education and information platform focused on oncology. Based in Shanghai, China, the company collaborates with numerous reputable hospitals and institutions, both domestically and internationally, to address the information asymmetry in the cancer field. Liangyihui provides a comprehensive range of educational materials related to tumor treatment, including medical cases, conference information, online courses, and research reports. This platform serves as a valuable resource for oncologists and aims to enhance public understanding of cancer, promoting scientific knowledge and supporting efforts to prevent and combat the disease.
Wangdiantong
Series C in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.
Kunya Medical
Series C in 2020
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.
GalaxySpace
Series C in 2020
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.
GensKey
Series C in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.
Tongcheng Shenghuo
Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.
Lunit
Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company develops solutions for various medical imaging modalities, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. Lunit aims to enhance clinical decision-making for physicians by leveraging machine learning technology to provide accurate and consistent diagnoses. Its product offerings include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which includes AI-powered biomarkers for immuno-oncology. Lunit's deep learning technology has been recognized for its capabilities, ranking among the top in prestigious image recognition competitions, highlighting its innovative approach to processing medical imaging data and utilizing weakly labeled data for improved pattern recognition.
Dongfang Weiyin
Series C in 2019
Dongfang Weiyin is a small and micro enterprise financial service platform.
Suzhou Ribo Life Science
Series C in 2019
Suzhou Ribo Life Science Co., Ltd. specializes in the development of nucleic acid drugs utilizing RNA interference (RNAi) technology, with a particular focus on treating liver diseases. Founded in 2007 and based in Kunshan, China, the company engages in various aspects of drug development, including drug discovery, siRNA design and screening, chemical modification, delivery technology, pharmacodynamics and pharmacokinetics studies, safety evaluation, and clinical trials. Suzhou Ribo Life Science offers siRNA therapeutics targeting conditions such as Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV. The company has established a strategic partnership with Quark Pharmaceuticals, Inc. to enhance its research and development capabilities.
GKHT Medical Technology
Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd., established in February 2013, is a company based in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., a subsidiary of the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. The company specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, Guoke Hengtai has experienced significant growth, achieving a compound annual growth rate exceeding 50% over four years and embarking on an initial public offering journey in 2017.
Zongmu
Series C in 2019
ZongMu Technology, established in January 2013 and based in the Pudong ZhangJiang high-tech park of Shanghai, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has research and development centers located in Beijing and Shenzhen. ZongMu has gained a strong foothold in the Chinese automotive market by providing innovative SurroundView ADAS solutions, which include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems. Through its commitment to quality and service, ZongMu has become a leading vendor in the SurroundView ADAS segment and has formed strategic partnerships with various original equipment manufacturers (OEMs) and their tier-one suppliers.
DeepWise
Series C in 2019
Beijing DeepWise Science and Technology Co., Ltd. specializes in artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and headquartered in Beijing, the company focuses on the early screening and diagnosis of various malignant diseases, including lung and breast cancer. It serves a diverse clientele, including hospitals, medical centers, and third-party imaging facilities. DeepWise's innovative software leverages advanced technology to improve diagnostic accuracy and efficiency, facilitating online consultations and data analysis through cloud-based solutions. By providing these services, DeepWise aims to support healthcare providers in both domestic and international markets in their efforts to detect and treat diseases effectively.
Bangsun Technology
Series C in 2019
Bangsun Technology is a Hangzhou-based real-time financial risk management company. It provides services including payment anti-fraud, application anti-fraud, Internet lending, data service, robot defense and anti-money laundering for financial institutions.
New Horizon Health
Series C in 2019
New Horizon Health develops advanced technology for the detection and screening of gastrointestinal cancers, with a primary focus on colorectal cancer. The company offers innovative products that utilize fecal gene analysis, allowing individuals to perform home tests that can identify signs of colon cancer and detect precancerous lesions more effectively than traditional blood tests. Established in 2015 and headquartered in Hangzhou, China, with an office in Beijing, New Horizon Health aims to enhance cancer screening accessibility through biotechnology. The company is dedicated to reducing cancer morbidity and mortality rates by promoting early detection and preventive measures, ensuring that high-quality health services reach households across the region. Its product lineup includes ColoClear and Pupu Tube, which are key revenue generators within its pipeline of screening solutions.
Safe Medical Evaluation
Series C in 2018
Beijing Saifu Medical Research Institute Co., Ltd. relies on the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the National Drug Safety Evaluation and Research Center of the State of Beijing to establish strategic partnerships with them to form a combination of technology, capital and enterprise operations. The core members of the company are researchers of the Institute of Materia Medica of the Chinese Academy of Sciences and researchers of the Academy of Military Medical Sciences. They have high scientific research and academic status in the fields of drug research and development and toxicology research, as well as rich drug development, GLP management and technical experience, and build and operate the platform. Provides strong talent and technical support.
Akulaku
Series C in 2018
Akulaku Inc., founded in 2016 and based in Jakarta, Indonesia, is a prominent banking and digital finance platform in Southeast Asia, operating in countries such as Indonesia, the Philippines, and Malaysia. The company focuses on addressing the financial needs of underserved customers in emerging markets by providing a variety of services, including digital banking, financing, investment, and insurance brokerage. Akulaku offers a virtual credit card and an e-commerce platform, along with Asetku, an online wealth management service, and a mobile digital bank known as Neobank, which is supported by Bank Neo Commerce. The company aims to enhance users' shopping experiences by facilitating installment purchases and providing a wide range of virtual payment services, such as mobile top-ups and bill payments. Akulaku's mission is to serve 50 million users across Southeast Asia by 2025.
Udesk
Series C in 2018
Udesk Ltd. is a customer experience solution provider based in Beijing, China, founded in 2014. The company offers an integrated platform that facilitates omnichannel communication, including call center operations, online customer service, and work order systems. Udesk enhances customer interactions across various channels such as text, mobile, phone, email, chat, and social media. Its solutions incorporate artificial intelligence, big data, and cloud computing technologies to improve customer relationship management and optimize marketing and customer success operations. Udesk serves a diverse range of industries, including healthcare, logistics, retail, education, and banking, among others. The company emphasizes connectivity and responsiveness to prioritize customer satisfaction.
Zhenkunxing
Series C in 2018
ZKH is a digital service platform for industrial products that offers comprehensive supply chain solutions based on an E-commerce platform, digital tools, and intelligent service. Its platform offers a comprehensive selection of industrial accessories, consumables, general equipment, and spare parts. There are 28 product lines and over 4 million SKUs available, including PPE, hand tools, metal processing, fasteners, instruments, chemicals, and so on.
Zongmu
Series C in 2018
ZongMu Technology, established in January 2013 and based in the Pudong ZhangJiang high-tech park of Shanghai, specializes in advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has research and development centers located in Beijing and Shenzhen. ZongMu has gained a strong foothold in the Chinese automotive market by providing innovative SurroundView ADAS solutions, which include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems. Through its commitment to quality and service, ZongMu has become a leading vendor in the SurroundView ADAS segment and has formed strategic partnerships with various original equipment manufacturers (OEMs) and their tier-one suppliers.
Taihe Music Group
Series C in 2018
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.
JollyChic
Series C in 2018
JollyChic is an e-commerce platform founded in 2012 by Aaron Li, headquartered in China. It specializes in the online retail of a diverse range of consumer products, including clothing, shoes, bags, babywear, home goods, electronics, and various accessories. The platform aims to provide quality and stylish products at competitive prices, catering to a broad customer base. JollyChic's offerings also extend to items such as toys, bedding, wedding supplies, and cleaning tools, making it a comprehensive destination for online shoppers seeking a variety of products.
NewsDog
Series C in 2018
NewsDog is a news and entertainment content aggregator that operates a platform known as WeMedia, which enables users to submit and share stories. With over 30,000 regular contributors, the platform caters to both Indian and international markets. NewsDog supports self-media authors and professional content creators, allowing them to showcase their work while utilizing machine learning technology to provide personalized news aggregation. This approach helps users efficiently access updated information and news. The company faces competition from other players in the industry, including Dailyhunt, Inshorts, and NewsPoint.
Uoko.com
Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Onion Math
Series C in 2018
Onion Math is an online education platform.
Fuyou Kache
Series C in 2018
Fuyoukache provides long distance truck logistics services to enterprises, individuals and large third-party logistics companies, connecting truck drivers with those in need of logistic services via its online platform.
Phoenix Travel Worldwide
Series C in 2017
Phoenix Travel Worldwide Co., Ltd. is a prominent international travel agency based in Beijing, China, specializing in outbound tourism services across Europe, the United States, Australia, Africa, and the Asia Pacific. Founded in 1997, the company has developed into a leading tourism resource integration enterprise in China, with a workforce exceeding one thousand employees and multiple branch offices in major cities including Shanghai, Chengdu, and Nanjing. Phoenix Travel is recognized as a 5A-level travel agency in Beijing and ranks among the top travel agencies nationally. The company offers a diverse portfolio of over 2000 tourist routes across more than 100 countries and regions, operating under four brands: Globaljoy, Mostour, Star Tour, and East Travel Holiday. In addition to its core outbound tourism services, Phoenix Travel also excels in high-end tourism, commercial tourism, airline ticketing, visa services, and various specialty travel experiences.
Zuoyebang
Series C in 2017
Zuoyebang is an online education startup based in Beijing, China, founded in 2014 by Hou Jianbin. The company focuses on providing educational products and services for primary and high school students, utilizing artificial intelligence to enhance learning experiences. Its platform allows students to upload homework questions and seek answers, making it easier for them to tackle study-related challenges. In addition to homework assistance, Zuoyebang offers online courses, live lessons, and evaluations for students from kindergarten through 12th grade. The company has gained significant backing from prominent investors, including Baidu, Alibaba Group, Tiger Global Management, SoftBank Vision Fund, Sequoia Capital China, and FountainVest Partners.
Axonics Modulation Technologies
Series C in 2017
Axonics Modulation Technologies, Inc. is a medical technology company focused on developing and commercializing sacral neuromodulation (SNM) systems for the treatment of conditions such as overactive bladder, urinary urge incontinence, urinary urgency frequency, fecal incontinence, and non-obstructive urinary retention. The company's proprietary rechargeable SNM system delivers mild electrical pulses to the sacral nerve, aiming to restore normal communication between the brain and the bladder or bowel, thereby alleviating symptoms associated with these dysfunctions. Originally known as American Restorative Medicine, Inc., the company rebranded in August 2013 and was incorporated in 2012. Headquartered in Irvine, California, Axonics is dedicated to addressing various clinical indications through innovative implantable neuromodulation technology.
Fuyou Kache
Series C in 2017
Fuyoukache provides long distance truck logistics services to enterprises, individuals and large third-party logistics companies, connecting truck drivers with those in need of logistic services via its online platform.
AtourHotel
Series C in 2016
Atour Hotel, founded in 2012 and based in Shanghai, China, operates as an upper-midscale hotel chain that provides a range of hospitality services. The company generates revenue through franchise and management fees from its managed hotels, as well as through the operation of leased hotels and the sale of hotel supplies and retail products. With a focus on enhancing guest experiences, Atour Hotel is committed to establishing a strong presence in the competitive hospitality market in China. The company’s operational structure consists of a single segment known as the Atour Group, which encompasses its various hospitality offerings.
Quna
Series C in 2016
Quna operates an online media and information service platform in China with the goal of improving marketing and sales experiences. The company collaborates with large e-commerce operators and consumer goods enterprises to provide free-trial items to the public, allowing users to pay for their user experience at levels that satisfy them.
MODERN SKY
Series C in 2016
Modern Sky is a music company that provides services in covering music publishing, artist brokerage, live music, visual and product design, retail and performance venues, recording and production, media, exhibitions, and hotel design. The company offers a favorable environment for development.
Musical.Ly
Series C in 2016
Founded in 2014, by creator Alex Zhu and longtime friend, Luyu Yang, musical.ly is a video social network for creating, sharing and discovering short videos. Every day, millions of teens use musical.ly as an outlet to express themselves through singing, dancing, comedy, and lip-syncing. The app celebrates creativity with videos recorded in 15 seconds or less that are shared across the musical.ly community. More than half of U.S. teens are users of musical.ly. Since first being made available in October 2014, musical.ly has hit #1 in the iOS App Store for free apps in 20 countries - including the United States. In 2017 Musical.ly was acquired by ByteDance subsidiary Toutiao, and in 2018 Musical.ly was merged into ByteDance subsidiary TikTok.
Haizhi Wangju Internet Technology
Series C in 2016
BDP (Business Data Platform) by a sea of production. Sea of co-founded by former Baidu founding team members and executives, core team members from Baidu, Microsoft, IBM, EMC, Silicon Valley veteran Internet and IT experts, has received a number of top venture capital co-investment fund.
AoHua
Series C in 2016
Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.
JenaValve Technology
Series C in 2015
JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.
UCloud Information Technology
Series C in 2015
UCloud Information Technology provides IaaS (base cloud computing), independent research and development, computational resource, storage resource, network resource, and other basic IT infrastructure services. It offers UCloud Physical Host that provides physical servers, UCloud Host, a UCloud-based mature cloud computing technology, UCloud Load Balancer, a load balancing service that offers automatic allocation of application data among multiple cloud hosts, UCloud Network, a UCloud network service that manages network resources, and UCloud Extended Hybrid Cloud that offers a hybrid deployment service of cloud platforms and server hosting. UCloud Information Technology also provides UCloud Disk that provides permanent hard disk storage space for cloud hosting, UCloud DataBase, a data base service based on mature cloud computing technology, UCloud Memory Storage, a key-value memory database, UCloud Content Delivery Network services, Object Storage that provides unstructured file storage services for Internet applications, UCloud Distributed Data Processing solutions, Cloud Security that provides testing services, and scheduling interface solutions for cloud computing resources. It serves video, O2O and E-Commerce, Internet finance, PaaS/SaaS, game, mobile SNS, online education, and digital marketing sectors. Ji Xinhua, Hua Kun, and Mo Xianfeng founded UCloud Information Technology in 2011. Its headquarters is in Shanghai in China.
FinVolution Group
Series C in 2015
FinVolution Group, formerly known as PPDai, is an online platform for peer-to-peer small unsecured loans in China. It builds a safe, high-performance, honest network platform with creative technology and ideals. FinVolution Group standardizes personal behaviors of debit and credit and brings returns to both lenders and borrowers. FinVolution was founded in August 2007 by founders from well-known companies.
Innovent Biologics
Series C in 2015
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
Bionano Genomics
Series C in 2014
Bionano Genomics is a biotechnology company that specializes in genome mapping and analysis, focusing on structural variation detection in DNA. The company develops the Saphyr system, which offers ultra-sensitive and specific detection of structural variations—such as insertions, deletions, inversions, and translocations—linked to various genetic disorders, including cancer. Utilizing optical genome mapping technology, the Saphyr system enables the direct visualization of long DNA molecules and their structural variations without the need for sequencing. This capability is crucial for researchers and clinicians aiming to gain insights into disease mechanisms and genetic disorders, ultimately aiding in the development of personalized treatment strategies. Bionano Genomics markets its products primarily to academic and governmental laboratories, as well as pharmaceutical and biotechnology companies across multiple regions, including North America, Europe, and Asia. Headquartered in San Diego, California, the company was founded in 2003 and was previously known as BioNano Genomics, Inc. until its name change in July 2018.
Wish
Series C in 2014
Wish is an e-commerce platform, putting a digital shopping mall of affordable goods directly in the pockets of consumers worldwide. Wish employs big data principles, machine-learning, and search technologies to create a highly-visual, entertaining, and personalized browsing experience for each user. The company leverages a global network of directsuppliers, providing access to top quality, affordable products to anyone with a smartphone. As of 2018, Wish has more than 80 million monthly active users, over one million merchants, and sells nearly 1 billion products annually. For more information about the company or to download the Wish mobile app.
JenaValve Technology
Series C in 2014
JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.
Social Touch
Series C in 2013
Established in 2011, Social Touch is a prominent provider of mobile social marketing solutions in China, focusing on helping businesses create a user-centered marketing ecosystem. The company offers a social media management software that facilitates marketing across various Chinese social networks. Its platform integrates corporate brand strategies with mobile marketing, enabling precise advertising and automated marketing management. By leveraging digital marketing, software engineering, and data mining strategies, Social Touch assists clients in realizing the full potential of mobile marketing, positioning itself as a comprehensive solution for companies seeking to enhance their marketing efforts in a dynamic digital landscape.
Shenogen Pharma Group
Series C in 2013
Shenogen Pharma Group is a drug discovery and development company.
JenaValve Technology
Series C in 2013
JenaValve Technology, Inc. is a medical device company specializing in the development and manufacturing of transcatheter aortic valve replacement (TAVR) systems designed for patients with severe aortic stenosis and aortic regurgitation. The company's flagship product, the Trilogy Heart Valve System, features a porcine pericardial trileaflet valve mounted on a self-expanding nitinol frame, which allows for both transapical and transfemoral implantation. This innovative system is particularly aimed at high-risk patients and has received CE Mark approval, as well as Breakthrough Device Designation from the U.S. Food and Drug Administration to expedite its review process in the United States. JenaValve operates from its headquarters in Irvine, California, with additional facilities in Munich, Germany, and Leeds, United Kingdom. The company aims to transform the treatment landscape for heart valve diseases through its advanced technologies.
Gaopeng
Series C in 2011
Gaopeng.com operates as a group-buying website in China. It is an online portal that offers discounts to customers at local merchants in China via daily emails. Gaopeng.com is financed by Groupon and Tencent, each of which owns 50% of the share. The site combines Groupon’s global group-buying operation experience with Tencent’s large user base. In August 2012, Gaopeng.com and Ftuan.com merged into one company named Wangluotianxia, and Lin Ning was appointed as its chief executive officer. Tencent and Groupon invested 40 million U.S. dollars in the new company and became principal shareholders together with the management team. Gaopeng.com was launched on February 15, 2011.
Pharmaron
Series C in 2011
Pharmaron Beijing Co Ltd is a research and development service provider in the life sciences sector, specializing in a comprehensive range of services for drug discovery, preclinical, and clinical development. The company supports various therapeutic modalities, including small molecules, biologics, and cell and gene therapies. Pharmaron's offerings encompass laboratory chemistry, biosciences, drug metabolism and pharmacokinetics (DMPK), pharmacology, drug safety assessments, and clinical development services. Its operations are divided into several segments, with laboratory services generating the highest revenue. By providing these essential services, Pharmaron plays a crucial role in advancing the drug development process for its clients.
Bonovo Orthopedics
Series C in 2010
Bonovo Orthopedics, Inc. specializes in the development, manufacturing, distribution, and sale of orthopedic implants and related products for the Chinese healthcare market. Established in 2005 and headquartered in Scottsdale, Arizona, the company offers a diverse range of products, including artificial discs, spinal fixation systems, hip and knee joint replacements, and bone void fillers. Additionally, Bonovo provides minimally invasive surgical solutions, such as kyphoplasty systems for vertebral fractures, along with various surgical instruments and devices. With over 15 years of experience and strong partnerships with leading clinicians and hospitals, Bonovo is well-positioned to meet the demands of the Chinese orthopedic market. The company operates manufacturing facilities in Beijing and Shanghai, ensuring efficient production and distribution of its innovative orthopedic solutions.
Lakala
Series C in 2009
Lakala Payment is a consumer financial services company in China. It caters to well-known convenience stores, supermarkets, shopping malls, and community groceries. It also offers services for credit card repayment and utility payment transactions. Customers can conduct various financial functions such as payment, repayment, recharging, and transfer-at-home thus reducing the pressure of traffic on bank counters. Lakala was launched in 2005 and is based in Beijing, China.
Bitauto Holdings
Series C in 2007
Bitauto Holdings Limited is a prominent provider of internet content and marketing services tailored for China's rapidly expanding automotive industry. The company operates through three primary segments: advertising and subscription services, transaction services, and digital marketing solutions. Its advertising segment offers services to automakers via websites and mobile applications, facilitating transaction-focused online advertisements and promotional activities. The transaction services segment supports automotive dealers, finance partners, and insurance companies, enhancing their operational capabilities. Additionally, Bitauto's digital marketing solutions encompass website creation and maintenance, online public relations, marketing campaigns, and big data applications, catering to various stakeholders in the automotive sector.
UNISOC
Series C in 2004
UNISOC is a fabless semiconductor company specializing in the research and development of core chipsets for mobile communications and the Internet of Things (IoT). The company produces a wide range of products, including mobile chipset platforms that support various communication standards such as 2G, 3G, and 4G, as well as RF chipsets, wireless connection chipsets, security chipsets, TV chipsets, and image sensor chipsets. With a global workforce of over 4,500 employees and numerous research and development centers, UNISOC ranks among the top three suppliers of mobile baseband chipsets worldwide and is the largest pan-chip supplier in China. The company's offerings enable access to advanced technologies, including 5G and artificial intelligence, for consumer and industrial electronics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.